These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 29162879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
    Zhang Q, Zhou X, Wan M, Zeng X, Luo J, Xu Y, Ji L, Zhang JA, Fan P, Zhong J, Wu J.
    Cell Death Dis; 2021 Mar 15; 12(3):275. PubMed ID: 33723215
    [Abstract] [Full Text] [Related]

  • 5. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
    Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ.
    J Mol Cell Biol; 2013 Feb 15; 5(1):3-13. PubMed ID: 22935141
    [Abstract] [Full Text] [Related]

  • 6. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Qiu Y, Yagüe E, Ji W, Liu J, Zhang J.
    Cell Death Dis; 2016 Jun 30; 7(6):e2291. PubMed ID: 27362808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X, Wang YW, Xing AY, Xiang S, Shi DB, Liu L, Li YX, Gao P.
    J Pathol; 2016 Aug 30; 239(4):459-72. PubMed ID: 27171498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
    Chen Y, Hao SA, Jiang Y, Gao B, Tian WG, Zhang S, Guo LJ, Wang LL, Luo DL.
    Eur Rev Med Pharmacol Sci; 2019 Sep 30; 23(18):7989-7999. PubMed ID: 31599424
    [Abstract] [Full Text] [Related]

  • 13. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W, Wu S, Wu Q, Zhou L, Yu L, Zhu B, Gong X.
    J Cell Biochem; 2019 Aug 30; 120(8):14095-14106. PubMed ID: 31087707
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS.
    Song YK, Wang Y, Wen YY, Zhao P, Bian ZJ.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818809997. PubMed ID: 30384806
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR, Lee ST, Kim SL, Zhu SM, Lee MR, Kim SH, Kim IH, Lee SO, Seo SY, Kim SW.
    Cancer Genet; 2019 Feb 01; 231-232():22-31. PubMed ID: 30803553
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway.
    Zhang F, Liu J, Xie BB.
    J Cell Physiol; 2019 Aug 01; 234(10):18626-18638. PubMed ID: 31049956
    [Abstract] [Full Text] [Related]

  • 19. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
    Bao C, Chen J, Chen D, Lu Y, Lou W, Ding B, Xu L, Fan W.
    Cell Death Dis; 2020 Aug 14; 11(8):618. PubMed ID: 32796817
    [Abstract] [Full Text] [Related]

  • 20. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
    Wang Y, Dong L, Wan F, Chen F, Liu D, Chen D, Long J.
    Cell Death Dis; 2021 Sep 22; 12(10):861. PubMed ID: 34552061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.